Royalty Report: Medical, Device, Catheter – Collection: 195625

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 10

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 10

Primary Industries

  • Medical
  • Device
  • Catheter
  • Stent
  • Supply
  • Surgical
  • Coating
  • cardiac
  • Diagnostic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 195625

License Grant
Licensor, an individual, hereby agrees to assign to the Company all of his right, title and interest to the inventions (the 'Inventions') and related patent rights.
License Property
The Inventions shall consist of the inventions described in 'Daisy Occluder and Method for Septal Defect Repair' (U.S. Patent Application filed on August 28, 1996, App. No. 08/697,837).
Field of Use
08/697,837 (5,741,297) The present invention relates to an occluder structure and method for the repair of intracardiac and vascular septal defects, as well as other abnormal openings in tissue planes such as the abdominal wall.

A septum, which is a thin wall of muscle or tissue which divides two or more chambers of the heart or other anatomic spaces of the human body, sometimes is perforated by an abnormal aperture passing through the septum, described as a septal defect. When septal defects occur between adjacent chambers of the heart or its associated major blood vessels, blood can leak from one chamber or artery to another imposing added strain on the heart which may lead to heart failure. An opening in the abdominal wall may allow bowel to pass through it, causing a hernia.

The surgical repair of intracardiac defects has required the use of open chest surgical techniques wherein the defect is directly sutured shut.

IPSCIO Record ID: 4808

License Grant
In connection with its Septal repair device, the Company has obtained an exclusive worldwide license from the Licensor, a non-profit health care organization.
License Property
United States patents entitled Occluder and Method for Repair of Cardiac and Vascular Defects and Occluder for Repair of Cardiac and Vascular Defects and the respective corresponding foreign patents, patent applications and associated know-how.

IPSCIO Record ID: 5941

License Grant
Licensee acquired the exclusive rights to the CardioSEAL® cardiac septal repair implant from the Licensor, a non-profit health care organization.   In connection with this acquisition, the Licensee acquired all of the existing development, manufacturing, testing equipment, patent Licenses, know-how and documentation necessary to manufacture cardiac septal repair implant devices. Under the License Agreements, as amended, the Licensee pays royalties to the Licensor on all commercial sales of our cardiac septal repair products. The Territory for sales of CardioSEAL® is the United States, Canada and Europe. The Licensee sells STARFlex® in Europe.
License Property
CardioSEAL® and STARFlex® are revolutionary products designed to close different types of holes in the heart without open heart surgery.  CardioSEAL®, a third generation implant, is constructed from a low profile, metal framework shaped like an umbrella to which a knitted polyester fabric is securely attached. CardioSEAL is comprised of two of these umbrellas, one for each side of the septum. Both the metal and fabric are made from the most biocompatible materials known for this application. The framework in particular has been selected for its excellent biocompatibility profile. After all, this implant will be in place for the life of the patient.

The Licensee has an exclusive worldwide License from the Licensor under United States patents entitled Occluder and Method for Repair of Cardiac and Vascular Defects (U.S. Patent No. 5,425,744), Occluder for Repair of Cardiac and Vascular Defects (U.S. Patent No. 5,451,235) and Self-Centering Umbrella-Type Septal Closure Device (U.S. Patent No. 5,709,707) and the respective corresponding foreign patents, patent applications and associated know-how.

Field of Use
The rights granted apply to cardiac products.

IPSCIO Record ID: 28651

License Grant
Assignors, two individuals, hereby sell, assign, and transfer exclusively and subject to all of the terms and conditions of this Agreement, their entire right, title, and interest in and to the Device and the Intellectual Property.
License Property
“Applications” shall mean any and all pending patent applications filed by Assignors relating to the Device and any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure designed or used by Assignors, including, but not limited to, the following
(a) In the United States, application No. 09/733,224 entitled Annuloplasty System, filed December 8, 2000;
(b) In Canada, application No. 2,197,069 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995;
(c) In the European Region, application No. 95929486.9 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995; and
(d) In Japan, application No. 507532/1996 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995 and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which either Segmed or Dr. Northrup is an inventor, which relate to the Device and/or any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom; and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by either or both of the Assignors, and any patent applications therefor and any patents issuing therefrom.

“Device” shall mean the apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure (the “Field”) covered by the Intellectual Property and fully described in the Applications and applications relating to the Patents, and any and all improvements, modifications, derivations, enhancements, technology, Know-how and Documentation related thereto.

Patent relates to a new annuloplasty technology for the repair of mitral and tricuspid heart valves.

“Patents” shall mean the following patents issued to Assignors in the United States, Australia, Taiwan and South Africa
(a) In the United States, U.S. Patent No. 5,593,424 entitled Apparatus and Method for Reducing and Stabilizing the Circumference of a Vascular Structure, issued January 14, 1997, U.S. Patent No. 5,709,695 entitled Apparatus for Reducing the Circumference of a Vascular Structure, issued January 20, 1998, and U.S. Patent No. 5,961,539 entitled Method and Apparatus for Sizing, Stabilizing and/or Reducing the Circumference of an Anatomical Structure, issued October 5, 1999;
(b) In Australia, patent No. 700530 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995;
(c) In Taiwan, patent No. 096871 entitled Apparatus for Reducing the Circumference of a Bodily Structure, filed August 11, 1995; and
(d) In South Africa patent No. 95/6672 entitled Apparatus and Method for Reducing the Circumference of a Vascular Structure, filed August 10, 1995,
and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which Assignors are an inventor, which relate to the Device and/or any apparatus or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom, and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by Assignors, and any patent applications therefor and any patents issuing therefrom.

“Trademark” shall mean the mark represented by United States Registration No. 2,108,883 for the “SEGMENT” mark.

IPSCIO Record ID: 2357

License Grant
Licensor and Licensee have  entered into agreement relating to certain technology.
License Property
'Licensed Products' shall mean any product, good, or item within the Field, produced in whole or in part, using a part or all of the technology embodied in Licensed Patents, and made of, but not limited to, Fluorinated Hydrocarbons (including, but not limited to, PTFE, ePTFE, FEP, PFA, HFP and VF).

A. Soft Tissue Includes Gore patch products used in the following applications
i)  Reconstruction of hernias and soft tissue deficiencies, such as abdominal wall defects, diaphragmatic hernia, laparoscopic hernia, pelvic floor and lid reconstruction, ventral hernia, laparoscopic inguinal hernia, muscle flap reconstruction, vaginal prolapse, rectal prolapse, scrotal hernia, gastric banding and temporary facial bridging; and
ii)  Plastic and reconstructive surgery, such as malarplasty, mentoplasty, rhinoplasty, maxilloplasty, frontal defects, reconstructive lip augmentations, orbital repair, facial folds, facial slings and auricuoplasty.

B. Cardiovascular Includes Gore patch products used in cardiovascular and cardiac patching, such as carotid patch, angioplasty, profundaplasty, AV access graft patching, septal defects, outflow tracts, aneurysm repair and other patch angioplasty.

C. Surgical Membrane/Adhesion Limiting Includes Gore patch products used in the following applications
i)   Reconstruction or repair of the peritoneum, where minimal adhesions to a prosthetic material are desired, such as infertility surgery, gynecological surgery and gynecological and surgical oncology;
ii)  Temporary or permanent prosthesis for the repair of dura mater during neurosurgery, such as tumor resection, tethered cord releases, trauma repair and Chiari decompression;
iii) Reconstruction of the pericardium where minimal adhesions are desired; and
iv)  Wrap for pedicled arterial conduits.

IPSCIO Record ID: 27403

License Grant
The Company owns exclusive, worldwide, perpetual licenses to develop, manufacture and market its Flo-Rester products from an undisclosed Licensor.
License Property
Flo-Rester products are vessel occluders manufactured from medical grade silicone.  The Flo-Rester products are designed to interrupt blood flow in arteries and to stent (hold open) them during surgery, thereby facilitating the suturing together of vessels.  Flo-Rester consists of a flexible shaft with small bulbs at each end that are inserted into the blood vessel at the point where the artery bypass is sutured to the artery to stop the blood flow.

IPSCIO Record ID: 6158

License Grant
The Licensee and the Licensors, two individuals, entered into a worldwide License agreement for  the Invention, including without limitation the entire right, title and interest to the Patent Rights to the  Atrial Septal Defect (ASD) and a Patent Ductus Arteriosus (PDA) Device Percutaneous Catheter Directed Intravascular Occlusion Devices – US Patent 5725552 .  The agreement shall continue in full force and effect for the commercial life of all products covered under this Agreement unless otherwise terminated. Inventors also grant the Licensee the exclusive right, but not the obligation, to use one or all of the inventors, names in its name or trademark for any Products and to use one or all of the inventors’ names in connection with the advertising and marketing of Products.  Intra-cardiac devices are used in various medical procedures
License Property
Atrial septal defect (ASD) is a form of congenital heart defect that enables blood flow between two compartments of the heart called the left and right atria.
Patent ductus arteriosus (PDA) is a congenital disorder in the heart wherein a neonate's ductus arteriosus fails to close after birth.

IPSCIO Record ID: 294278

License Grant
Licensor hereby grants to Licensee and its Affiliates an exclusive license in the Territory, bearing royalties as set forth in this Agreement, with the right to grant sublicenses, under the Licensor Patents, Licensor Know-How and Other Licensor IP, to make, have made, use, sell, offer for sale and import Products for use solely in the Field and in the Territory.
License Property
PFO is a medical device known as the PFO Closure Device for use in patent foramen ovale.

Licensor Patents means a Patent that (a) claims the Product or any component thereof, or any other method, apparatus, material or article of manufacture useful in the development, manufacture, use or sale of Product, and (b) is Controlled by Licensor.

Product means the PFO Closure Device developed under this Agreement and described in the Device Description and Sequence of Operation as set forth.  The PFO closure device is intended to close a heart abnormality – the patent foreman ovale (PFO).

Patent means (a) unexpired United States and foreign patents, including without limitation any substitution, extension, registration, confirmation, reissue, re-examination, renewal of such patents and (b) pending applications for such patents, including without limitation any continuation, divisional or continuation-in-part thereof and any provisional applications.

A PFO closure device is moved through the vein to the heart, and specifically to the location of the heart wall defect. Once in the correct location, the PFO closure device is formed so that it straddles each side of the hole. The device will remain in the heart permanently to stop the abnormal flow of blood between the two atrial chambers of the heart. The catheter is then removed and the procedure is complete.

Field of Use
The Vascular Access Closure Device is an innovative automated system designed to close access openings in femoral arteries after interventional vascular procedures.

IPSCIO Record ID: 299236

License Grant
Under the initial agreement, the Canadian Licensor agreed to license on a co-exclusive certain patent rights, license rights, and technology.

This agreement is extending Licensee’s worldwide right and license to use, manufacture, have manufactured, distribute and sell, and to grant sublicenses to its Affiliates to use, manufacture, have manufactured, distribute and sell, the Licensor Technology in the Peripheral Vascular Field of Use and the GI Field of Use.

Licensor newly grants its licensee, the right for Licensee to have third party Distributors distribute Eligible Peripheral Vascular and/or GI Products.

This agreement is co-exclusive with an option to become exclusive.

License Property
This agreement is for paclitaxel or certain other agents as a coating for certain medical devices.

The license agreement regards paclitaxel-eluting stent products and related technologies.  Paclitaxel is released from the balloon or stent to prevent scar tissue formation in the blood vessel that can re-obstruct the artery (restenosis).

Field of Use
As used herein, the Coronary Vascular Field of Use means endoluminal vascular Licensed Applications for the treatment and/or prevention of disease of the coronary arteries and their branches, or other vasculature providing blood flow to the heart.

As used herein, the Peripheral Vascular Field of Use means the endoluminal vascular licensed applications for the treatment or preventionof disease of the peripheral blood vessels of the body.  Notwithstanding the foregoing, Peripheral Vascular Field of Use excludes any application in the Coronary Vascular Field of Use.  

GI Field of Use means the endoluminal licensed applications for the treatment or prevention of disease of the alimentary tract or liver.

IPSCIO Record ID: 310350

License Grant
Licensor grants a worldwide, non-transferable, and non-sub licensable license to make, have made, use and sell Licensed Products in the Field of Use.  The licensed granted shall be co-exclusive, meaning that Licensor or any Affiliate of Licensor shall also have the worldwide right to make, have made, use, sell or otherwise commercialize and exploit the Licensed Technology in the Field of Use, provided that Licensor shall not grant any licenses to the Licensed Technology in the Field of Use during the term of this Agreement.
License Property
Licensor has developed certain technology related to catheter navigation and mapping.

Licensor is a medical device company, with products including cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, and patient monitoring systems.

This agreement is for the technology, patent and applications are for Catheter Mapping System and Application, including, specifically, U.S Patent No 5,697,377, and all trade secrets and know-how owned by Licensor prior to the date of this Agreement which relate specifically and directly to 3-D electrode localization devices and techniques as disclosed in the patents or patent applications, including but not necessarily limited to software developed specifically to practice the inventions disclosed in the patents included in the Licensed Technology, and new patents arising out of patent applications filed, or inventions reduced to practice and relate specifically and directly to 3-D electrode localization devices and techniques.

Field of Use
The Field of Use shall mean electrophysiological intracardiac mapping applications for the treatment of cardiac arrhythmias.

Licensee is engaged in the development of the EnSite diagnostic catheter and clinical workstation for use by electrophysiologists in diagnosing and mapping abnormal heart rhythms known as tachycardias.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.